quinazolines has been researched along with Viral Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballon-Landa, E; Galen, B; Kalinowski, A; Knoff, D; Koff, JL; Lanier, LL; Min-Oo, G; Nadel, JA; Ueki, I | 1 |
| Jiang, J; Tang, X; Wang, Y; Yao, Y; Zhou, J | 1 |
| Lischka, P; Marschall, M; Ruebsamen-Schaeff, H; Stamminger, T; Urban, A; Wildum, S; Zimmermann, H | 1 |
| Dame, C; Sutor, AH | 1 |
1 review(s) available for quinazolines and Viral Diseases
| Article | Year |
|---|---|
Primary and secondary thrombocytosis in childhood.
Topics: Adolescent; Bacterial Infections; Blood Platelets; Child; Child, Preschool; Humans; Hydroxyurea; Infant; Infant, Newborn; Liver; Megakaryocytes; Mutation; Nucleic Acid Synthesis Inhibitors; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombocytosis; Thrombopoiesis; Thrombopoietin; Virus Diseases | 2005 |
3 other study(ies) available for quinazolines and Viral Diseases
| Article | Year |
|---|---|
EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production.
Topics: Bronchi; Cell Line; Cell Movement; Chemokine CXCL10; Epithelial Cells; ErbB Receptors; Female; Gefitinib; Humans; Influenza A Virus, H1N1 Subtype; Interferon Regulatory Factor-1; Interleukin-8; Killer Cells, Natural; Quinazolines; Respiratory Syncytial Viruses; Rhinovirus; Signal Transduction; Virus Diseases | 2014 |
Regulation of Viral Infection-induced Airway Remodeling Cytokine Production by the TLR3-EGFR Signaling Pathway in Human Bronchial Epithelial Cells.
Topics: Airway Remodeling; Antiviral Agents; Bronchi; Cells, Cultured; Cytokines; ErbB Receptors; Flavonoids; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mucin 5AC; p38 Mitogen-Activated Protein Kinases; Poly I-C; Protein Kinase Inhibitors; Quinazolines; Respiratory Mucosa; RNA, Messenger; Toll-Like Receptor 3; Transforming Growth Factor beta1; Tyrphostins; Vascular Endothelial Growth Factor A; Virus Diseases | 2016 |
In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Herpesviridae; Humans; Microbial Sensitivity Tests; Quinazolines; Species Specificity; Virus Diseases; Viruses | 2012 |